The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro
Makoto Kawamoto(Kyushu University), Hideya Onishi(Pancreas Centre (Canada))
Cited by 5
Related Papers
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer
|Anticancer Research|2018|20
Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy
|Journal of Immunotherapy|2019|17
Abstract 4779: Coxsackievirus A11 as a novel oncolytic viral therapy for human colorectal cancer
|Cancer Research|2019|0
Abstract 4779: Coxsackievirus A11 as a novel oncolytic viral therapy for human colorectal cancer
|Experimental and Molecular Therapeutics|2019|0